
Jennifer Karlin, MD, PhD, explains how COVID-19 increased awareness of self-administered DMPA, but systemic and provider-level barriers still limit access.

Jennifer Karlin, MD, PhD; Associate professor, University of California, San Francisco.

Jennifer Karlin, MD, PhD, explains how COVID-19 increased awareness of self-administered DMPA, but systemic and provider-level barriers still limit access.